In last trading session, Annovis Bio Inc (NYSE:ANVS) saw 0.44 million shares changing hands with its beta currently measuring 1.58. Company’s recent per share price level of $2.05 trading at -$0.12 or -5.53% at ring of the bell on the day assigns it a market valuation of $39.95M. That closing price of ANVS’s stock is at a discount of -772.2% from its 52-week high price of $17.88 and is indicating a premium of 45.85% from its 52-week low price of $1.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.54 million shares which gives us an average trading volume of 482.91K if we extend that period to 3-months.
For Annovis Bio Inc (ANVS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Annovis Bio Inc (NYSE:ANVS) trade information
Upright in the red during last session for losing -5.53%, in the last five days ANVS remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $2.05 price level, adding 35.53% to its value on the day. Annovis Bio Inc’s shares saw a change of -63.13% in year-to-date performance and have moved -21.15% in past 5-day. Annovis Bio Inc (NYSE:ANVS) showed a performance of -15.64% in past 30-days. Number of shares sold short was 2.21 million shares which calculate 3.74 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 26 to the stock, which implies a rise of 92.12% to its current value. Analysts have been projecting 21 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -924.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -924.39% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -73.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 30.80% while estimates for its earnings growth in next 5 years are of 18.86%.
Annovis Bio Inc (NYSE:ANVS)’s Major holders
Insiders are in possession of 14.69% of company’s total shares while institution are holding 16.03 percent of that, with stock having share float percentage of 18.79%. Investors also watch the number of corporate investors in a company very closely, which is 16.03% institutions for Annovis Bio Inc that are currently holding shares of the company. LMR PARTNERS LLP is the top institutional holder at ANVS for having 0.57 million shares of worth $3.3 million. And as of 2024-06-30, it was holding 5.0594 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.36 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.1956 of outstanding shares, having a total worth of $2.08 million.
